Citadel Advisors’s Regulus Therapeutics RGLS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-148,280
Closed -$259K 6799
2025
Q1
$259K Sell
148,280
-7,278
-5% -$12.7K ﹤0.01% 4624
2024
Q4
$246K Buy
155,558
+155,526
+486,019% +$246K ﹤0.01% 4706
2024
Q3
$50 Buy
+32
New +$50 ﹤0.01% 5698
2024
Q2
Hold
0
6664
2024
Q1
Sell
-28,461
Closed -$36.4K 6729
2023
Q4
$36.4K Buy
28,461
+16,746
+143% +$21.4K ﹤0.01% 5224
2023
Q3
$16.2K Sell
11,715
-16,090
-58% -$22.2K ﹤0.01% 5352
2023
Q2
$40.9K Buy
27,805
+22,019
+381% +$32.4K ﹤0.01% 5055
2023
Q1
$4.9K Sell
5,786
-36,719
-86% -$31.1K ﹤0.01% 5611
2022
Q4
$58.2K Buy
+42,505
New +$58.2K ﹤0.01% 5228
2022
Q3
Sell
-23,655
Closed -$49K 6579
2022
Q2
$49K Buy
+23,655
New +$49K ﹤0.01% 5510
2022
Q1
Hold
0
6986
2021
Q4
Sell
-3,536
Closed -$24K 7060
2021
Q3
$24K Sell
3,536
-24,438
-87% -$166K ﹤0.01% 6268
2021
Q2
$227K Buy
27,974
+25,382
+979% +$206K ﹤0.01% 5450
2021
Q1
$40K Buy
+2,592
New +$40K ﹤0.01% 6135
2020
Q4
Sell
-10,880
Closed -$56K 5504
2020
Q3
$56K Buy
+10,880
New +$56K ﹤0.01% 4373
2019
Q1
Sell
-1,067
Closed -$10K 4940
2018
Q4
$10K Buy
+1,067
New +$10K ﹤0.01% 4407
2017
Q3
Sell
-94
Closed -$11K 4030
2017
Q2
$11K Sell
94
-167
-64% -$19.5K ﹤0.01% 3578
2017
Q1
$52K Buy
+261
New +$52K ﹤0.01% 3399
2016
Q4
Sell
-191
Closed -$76K 4007
2016
Q3
$76K Buy
191
+50
+35% +$19.9K ﹤0.01% 3235
2016
Q2
$49K Buy
141
+12
+9% +$4.17K ﹤0.01% 3064
2016
Q1
$107K Sell
129
-80
-38% -$66.4K ﹤0.01% 2867
2015
Q4
$219K Sell
209
-392
-65% -$411K ﹤0.01% 2911
2015
Q3
$471K Buy
601
+427
+245% +$335K ﹤0.01% 2647
2015
Q2
$228K Sell
174
-208
-54% -$273K ﹤0.01% 2978
2015
Q1
$776K Buy
382
+352
+1,173% +$715K ﹤0.01% 2349
2014
Q4
$57K Buy
+30
New +$57K ﹤0.01% 3376